Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
86M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
518K
-
Shares change
-
-2.72K
-
Total reported value, excl. options
-
$32.9M
-
Value change
-
+$124K
-
Number of buys
-
25
-
Number of sells
-
-18
-
Price
-
$64.81
Significant Holders of CRISPR Therapeutics AG - Common Stock (CRSP) as of Q3 2025
65 filings reported holding CRSP - CRISPR Therapeutics AG - Common Stock as of Q3 2025.
CRISPR Therapeutics AG - Common Stock (CRSP) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 518K shares
of 86M outstanding shares and own 0.6% of the company stock.
Largest 10 shareholders include Baker Chad R (93.2K shares), CONGRESS ASSET MANAGEMENT CO (68.1K shares), Green Alpha Advisors, LLC (55K shares), Koss-Olinger Consulting, LLC (42.2K shares), Voya Investment Management LLC (28.8K shares), Ipswich Investment Management Co., Inc. (25.2K shares), Patriot Financial Group Insurance Agency, LLC (23.3K shares), Hedges Asset Management LLC (22.5K shares), Asset Management One Co., Ltd. (22.1K shares), and Perigon Wealth Management, LLC (18.7K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.